Pars Plana Vitrectomy Without Intravenous Anesthesia: Technique, Safety, and Outcomes.

J Vitreoretin Dis

Colorado Retina Associates, Denver, CO, USA.

Published: June 2024

AI Article Synopsis

  • The study examined the safety and effectiveness of performing pars plana vitrectomy (PPV) without intravenous (IV) anesthesia, focusing on patient outcomes and adverse events.
  • Conducted between September 2018 and April 2022, the study involved 357 surgeries on 319 patients, with most receiving oral sedation and a small group undergoing the procedure without any sedation.
  • Results showed significant improvement in visual acuity post-surgery and no major complications, indicating that PPV can be performed safely without an anesthesiologist, though further research is suggested to better assess patient comfort and complications.

Article Abstract

To describe the technique, safety profile, and outcomes of performing pars plana vitrectomy (PPV) without intravenous (IV) anesthesia. This retrospective single-surgeon study comprised patients who had PPV without IV sedation between September 2018 and April 2022. Patients elected to undergo PPV without sedation or with oral sedation via sublingual triazolam administered 30 minutes preoperatively. Sub-Tenon bupivacaine and lidocaine were administered at the initiation of each case. A circulating nurse monitored patient vitals and electrocardiogram tracings without anesthesiologist support. Adverse events (AEs), visual acuity (VA), supplemental block administration, and reoperation rates were documented. A total of 357 PPVs in 319 patients (mean age 68.75 ± 11.17 years [SD]; range, 36.82-98.57) were performed for surgical indications including vitreous floaters, intraocular lens or cataract surgery complications, retinal detachment, vitreous hemorrhage, and epiretinal membrane. Twenty-three cases were performed without sedation, and 334 were performed with oral sedation. For eyes with a follow-up longer than 1 month (n = 324), the preoperative VA of 0.68 ± 0.77 logMAR improved to 0.31 ± 0.46 logMAR postoperatively ( < .01). No intraoperative complications, systemic AEs, need to cease surgery prematurely, or conversion to IV sedation occurred. Five eyes (1.77%) required intraoperative supplemental sub-Tenon block administration, and 95% of patients who had a reoperation n = 10) or fellow-eye surgery (n = 28) requested the same method of anesthesia without IV sedation. Vitreoretinal surgery with a sub-Tenon block and oral sedation can be safely performed without the support of an anesthesiologist. Additional trials are needed to further quantify patient comfort, surgeon experience, and complication rates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440523PMC
http://dx.doi.org/10.1177/24741264241260093DOI Listing

Publication Analysis

Top Keywords

pars plana
8
plana vitrectomy
8
intravenous anesthesia
8
technique safety
8
ppv sedation
8
oral sedation
8
sedation
5
vitrectomy intravenous
4
anesthesia technique
4
safety outcomes
4

Similar Publications

Purpose: To describe effects of sustained-release steroid delivery devices on intraocular pressure (IOP) in eyes with glaucoma drainage devices (GDD).

Methods: Retrospective case series of eyes with steroid implants (dexamethasone or fluocinolone acetonide) and prior GDD (Ahmed, Baerveldt) without uveitis. Outcomes included IOP, IOP rise, central foveal thickness (CFT), and IOP medications.

View Article and Find Full Text PDF

Purpose: To report on the clinical and cytopathological features of metastatic lung adenocarcinoma to the eye masquerading as an intermediate uveitis.

Methods: Retrospective chart review.

Results: A 63-year-old woman with a history of lung adenocarcinoma in remission presented with progressive vision loss and floaters in the right eye.

View Article and Find Full Text PDF

Coats disease presenting with vitreous hemorrhage and neovascular glaucoma.

Am J Ophthalmol Case Rep

March 2025

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, 60612, USA.

Purpose: To describe a patient with Coats disease with an atypical presentation of neovascular glaucoma and vitreous hemorrhage.

Observations: A 15-year-old male presented with five days of pain, redness, and swelling and was found to have neovascular glaucoma in his right eye. Further evaluation revealed Coats disease stage 3AI with a subtotal exudative retinal detachment inferiorly, telangiectatic vessels, and vitreous hemorrhage.

View Article and Find Full Text PDF

A patient with juvenile glaucoma status post 2 glaucoma drainage implants in each eye presents with painful vision loss in the left eye and is found to have streptococcus pneumoniae endophthalmitis from an exposed inferior glaucoma drainage implant. The infection is managed medically with intravitreal antibiotics and surgically with a glaucoma drainage device revision, anterior chamber washout and pars plana vitrectomy.

View Article and Find Full Text PDF

: This study aimed to assess the role of macular pigment optical density (MPOD) in patients with a full-thickness macular hole (FTMH) compared to healthy controls, evaluating postoperative changes in MPOD and exploring potential correlations with visual outcomes. : This prospective, cross-sectional, comparative study included 16 eyes from FTMH patients who achieved anatomical hole closure following pars plana vitrectomy with the inverted ILM flap technique. Each eye underwent a comprehensive ophthalmologic examination, including BCVA and intraocular pressure measurements, anterior segment evaluation, fundus examination, and macular assessment with Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT, Spectralis, Heidelberg Engineering Inc.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!